Ortho Evra Heart Attack/Stroke Risk Final Results Due In 2007, FDA Says
Preliminary analysis suggests two-fold greater risk of blood clots associated with J&J/Ortho-McNeil's transdermal contraceptive patch than with traditional oral contraceptives.
Preliminary analysis suggests two-fold greater risk of blood clots associated with J&J/Ortho-McNeil's transdermal contraceptive patch than with traditional oral contraceptives.